sivelestat has been researched along with Cancer of Stomach in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hihara, J; Konishi, K; Mizuiri, H; Suzuki, T; Tanabe, K; Taomoto, J; Ukon, K; Wada, Y; Yoshida, K | 1 |
1 other study(ies) available for sivelestat and Cancer of Stomach
| Article | Year |
|---|---|
Sivelestat, a specific neutrophil elastase inhibitor, suppresses the growth of gastric carcinoma cells by preventing the release of transforming growth factor-alpha.
Topics: Animals; Carcinoma; ErbB Receptors; Female; Glycine; Humans; Leukocyte Elastase; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 3; Neoplasm Transplantation; Phosphorylation; Serine Proteinase Inhibitors; Stomach Neoplasms; Sulfonamides; Transforming Growth Factor alpha; Xenograft Model Antitumor Assays | 2006 |